November marks American Diabetes Month, a time to reflect on the significant strides made in diabetes care over the past century. From the groundbreaking discovery of insulin in 1921 to today’s innovations, including long-acting insulins and new treatments like GLP-1 receptor agonists and SGLT2 inhibitors for type 2 diabetes, medical advancements have profoundly improved the health and quality of life for millions living with the condition.
These innovations have revolutionized diabetes management, enabling more precise and personalized treatment plans while greatly reducing the risks of severe complications. However, American Diabetes Month also serves as a reminder of the ongoing need for continued research to refine existing treatments and, ultimately, find a cure for the disease.
At PhRMA, we celebrate the progress made in diabetes care and honor the resilience of the millions impacted by the condition. We remain committed to collaborating with policymakers to ensure all Americans have access to the groundbreaking treatments that are improving lives every day.
Related topics:
Low Income Linked to Higher Mortality Risk in Type 2 Diabetes Patients
Tech and Research Transform Diabetes Management in Singapore
Blacktown Encourages Early Diabetes Detection with Free Screening Event
